 |
Developing Innovative Biotherapeutics driven by Unmet Medical Needs |
|
|
|
|
|
Bio2Device Group, Tuesday Morning, Feb. 28, 2012
Topic: “Developing Innovative Biotherapeutics driven by Unmet
Medical Needs”
Speaker: Xiaodong Yang, M.D.,CEO
Date and Time: Tuesday, Feb. 28, 2012, 8:30- 10:30 am
Location: Sunnyvale City Council Chambers, 456 W. Olive,
Sunnyvale, CA (across the street from Sunnyvale Public Library)
Cost: Free
Park in Street and in NOVA and library parking lots across the
street.02/28/2012 - 8:30am
Topic Description
In the current economic, financial and regulatory environment, it
has become increasingly challenging to develop innovative
biotherapeutics such as novel antibody-based therapeutics.
Apexigen is a start-up biopharma company focusing on discovery
and development of best-in-class antibody therapeutics for the
treatment of cancer and inflammation. At Apexigen, we believe
innovation in drug discovery and development must be driven by
the needs of patients. This presentation will illustrate and
discuss the opportunities and hurdles facing biopharma companies
in growing their businesses and achieving the ultimate goal of
delivering innovative medicines to patients.
Speaker Bio
Dr. Xiaodong Yang is President and Chief Executive Officer of
Apexigen which is a biopharma company focusing on development of
antibody therapeutics. He has over 15 years of experience in the
research and development of antibody and siRNA therapeutics.
Prior to joining Apexigen, Dr. Yang was Vice President of
Research and Preclinical Development at Intradigm Corporation
(now Silence Therapeutics). In this role, he was responsible for
overseeing the progress of company’s discovery and preclinical
development of RNAi-based therapeutics. Dr. Yang began his career
as a founding scientist at Abgenix (now Amgen). He was Senior
Director and the head of the Oncology Therapeutic Program Team
responsible for setting strategy and managing the company’s
oncology portfolio. Dr. Yang was the project team leader for
Vectibix® (panitumumab) and played a raine |
|
|
|
|
